For decades, the treatment of severe eczema has been stuck in a destructive loop. Doctors prescribe steroids to reduce inflammation, but prolonged use thins the skin and weakens immunity. When bacterial infections arise, antibiotics are deployed, but overuse creates resistant superbugs. The cycle repeats, and patients are left with worsening symptoms and fewer options. It is a war where every victory creates a stronger enemy.

This week, a team at Hong Kong University has proposed a radical alternative. Instead of killing bacteria, they neutralize the toxins that bacteria produce. The result is a plant-based formula called “Anesinin” that breaks the cycle without triggering antibiotic resistance or requiring steroids.

The breakthrough comes from the laboratory of Professor Yuen Kwok-yung, the microbiologist who discovered the SARS coronavirus and has spent over a decade studying the bacterial culprit behind eczema flare-ups: Staphylococcus aureus. This bacterium colonizes the skin of eczema patients and releases toxins that trigger intense itching, inflammation, and a breakdown of the skin barrier. The more you scratch, the more the bacteria invade. The more antibiotics you use, the stronger the bacteria become.

This is an AMAZING moment because it represents a fundamental shift in how we approach infection. Professor Yuen describes bacterial infection as a “human wave attack.” If you respond with antibiotics, you kill some bacteria, but survivors evolve resistance. Over time, you are left with fewer weapons and stronger enemies. The smarter strategy, he argues, is to disarm the attackers rather than kill them.

Anesinin does exactly that. The formula contains plant-derived compounds that block the “virulence factors” of S. aureus—the molecular weapons the bacteria use to damage tissue and trigger inflammation. By neutralizing these toxins, the formula stops the itching and inflammation at the source, without disturbing the skin’s natural microbiome. The bacteria remain on the skin, but they are rendered harmless.

Why does this matter to you? Because eczema affects one in five people in Hong Kong, and millions more worldwide. Current treatments are expensive, often ineffective, and come with serious side effects. Biologic drugs, which target the immune system, can cost tens of thousands of dollars per year. Steroids cause skin thinning and immune suppression. Antibiotics fuel the global crisis of antibiotic resistance.

Anesinin offers a different path. Developed with support from the Hong Kong government’s InnoHK platform, the formula has already been incorporated into skincare products. Professor Yuen’s next goal is to secure funding for large-scale clinical trials so that the treatment can be officially listed on the Hospital Authority’s prescription drug list. If successful, Anesinin could become an affordable, accessible option for patients who have been failed by conventional medicine.

The elegance of this approach lies in its philosophy. Rather than seeing bacteria as enemies to be eradicated, the treatment sees them as neighbors to be managed. This is the principle of “harmonious coexistence,” and it reflects a deeper understanding of how ecosystems—including the ecosystem of the human body—actually function. The skin is not a sterile battlefield. It is a complex community of microorganisms, and health depends on balance, not domination.

I am Henry P., and I believe this breakthrough is more than a new treatment for eczema. It is a blueprint for how we should approach antibiotic resistance, autoimmune disease, and the broader challenge of living in a microbial world. For too long, medicine has operated on the logic of eradication. Kill the virus. Kill the bacteria. Kill the cancer cell. But nature does not work that way. Life is a negotiation, not a war. And the treatments that will define the next era of medicine are the ones that understand this.

Professor Yuen has spent his career studying the most dangerous pathogens on Earth. He knows what it takes to fight an enemy. But he also knows when it is smarter to make peace. Anesinin is the result of that wisdom. It is a treatment that does not destroy. It disarms. It protects. And it offers a way forward for the millions of people who have been waiting for a solution that does not come with a cost they cannot afford.

Sources:
∙ RTHK (Radio Television Hong Kong), “HKU develops plant-based formula to treat eczema,” February 12, 2026.https://news.rthk.hk/rthk/en/component/k2/1843661-20260212.htm
∙ Sing Tao Daily (星島日報), “袁國勇團隊研發濕疹新療法「安思靈」,” February 11-12, 2026.https://www.stheadline.com/society/3544321/
∙ HKU Medical School, Professor Yuen Kwok-yung press conference on Anesinin eczema treatment, February 2026.https://www.med.hku.hk/